IMPACT ON PRODUCTIVITY ASSOCIATED WITH THE USE OF EMICIZUMAB IN PROPHYLAXIS FOR HEMOPHILIA A WITH INHIBITORS IN COLOMBIA

被引：0
|
作者：
Moreno, N. A. [1 ]
Munoz-Bedoya, A. [2 ]
机构：
[1] Productos Roche SA Colombia, Bogota, Colombia
[2] Productos Roche SA, Bogota, Colombia
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO33
引用
收藏
页码：S846 / S846
页数：1
相关论文
共 50 条
  • [1] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Aledort, Louis M.
    Ewenstein, Bruce M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2193 - 2193
  • [2] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Oldenburg, Johannes
    Mahlangu, Johnny N.
    Kim, Benjamin
    Schmitt, Christophe
    Callaghan, Michael U.
    Young, Guy
    Santagostino, Elena
    Kruse-Jarres, Rebecca
    Negrier, Claude
    Kessler, Craig
    Valente, Nancy
    Asikanius, Elina
    Levy, Gallia G.
    Windyga, Jerzy
    Shima, Midori
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 809 - 818
  • [3] ECONOMIC IMPACT OF EMICIZUMAB PROPHYLAXIS FOR HEMOPHILIA A WITH AND WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S699 - S699
  • [4] Emicizumab Prophylaxis in Hemophilia A with Inhibitors REPLY
    Oldenburg, Johannes
    Levy, Gallia G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2194 - 2195
  • [5] BUDGET IMPACT ANALYSIS OF THE USE OF EMICIZUMAB IN PROPHYLAXIS FOR SEVERE HEMOPHILIA A AND INHIBITORS IN THE PEDIATRIC COPULATION OF THE DOMINICAN REPUBLIC
    Munoz, A.
    Bustamante, A.
    Blanco, J.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S135 - S136
  • [6] Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With Inhibitors
    Watanabe, Alexandre Hikiji
    Lee, Shaun Wen Huey
    Chai-Adisaksopha, Chatree
    Lim, Ming Y.
    Chaiyakunapruk, Nathorn
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2022, 28 : 7 - 13
  • [7] EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A AND INHIBITORS: A SYSTEMATIC REVIEW
    Camelo, R.
    Prudente, T. P.
    Minare, D. V.
    Gomes, G. D. P. V. C.
    Roberti, M. D. R. F.
    [J]. HAEMOPHILIA, 2023, 29 : 53 - 54
  • [8] Emicizumab Prophylaxis in Patients with Hemophilia. with and without Inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    [J]. BLOOD, 2019, 134
  • [9] Emicizumab prophylaxis overcomes factor VIII inhibitors in Hemophilia A
    Shima, Midori
    [J]. JOURNAL OF PEDIATRICS, 2017, 190 : 289 - 289
  • [10] REDUCTION OF COSTS ASSOCIATED WITH THE USE OF EMICIZUMAB IN PROPHYLAXIS IN PEDIATRIC PATIENTS DIAGNOSED WITH SEVERE HEMOPHILIA A AND INHIBITORS IN EL SALVADOR
    Estrada, A.
    Galdamez, C.
    Castillo, D.
    Ventura, B.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S116 - S116
12345